Lexicon Pharmaceuticals | Passivo Circulante





Passivo Circulante Alterar Data
Abbott USD 14.58B 1.14B 2025-09
Acadia Pharmaceuticals USD 356.58M 26.56M 2025-09
Agios Pharmaceuticals USD 74.76M 4.35M 2025-09
Akebia Therapeutics USD 133.38M 14.66M 2025-09
Alnylam Pharmaceuticals USD 1.56B 254.63M 2025-09
AstraZeneca USD 34.05B 518M 2025-09
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Coherus Biosciences USD 372.3M 108.67M 2025-09
Eli Lilly USD 40.14B 1.12B 2025-09
Esperion Therapeutics USD 359.03M 60.24M 2025-09
Halozyme Therapeutics USD 837.23M 702.95M 2025-09
Illumina USD 1.59B 377M 2025-12
Insmed USD 417.21M 105.53M 2025-09
Ironwood Pharmaceuticals USD 242.5M 9.98M 2025-09
J&J USD 50.87B 3.31B 2025-09
Lexicon Pharmaceuticals USD 34.84M 75.86M 2025-06
MacroGenics USD 44.47M 5.47M 2025-09
MannKind USD 109.13M 2.7M 2025-09
Merck USD 28.63B 2.59B 2025-09
Moderna USD 1.68B 109M 2025-09
Novartis USD 32B 286M 2025-09
PTC Therapeutics USD 866.24M 238.44M 2025-09
Puma Biotechnology USD 82.73M 3.63M 2025-09
Sarepta Therapeutics USD 921.42M 1.48M 2025-09
Thermo Fisher Scientific USD 15.19B 301M 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
United Therapeutics USD 546.3M 19.2M 2025-09
Vanda Pharmaceuticals USD 117.87M 3.62M 2025-09


Lexicon Pharmaceuticals Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.